Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant

Transplant rejection is the critical clinical end-point limiting indefinite survival after histocompatibility antigen (HLA) mismatched organ transplantation. The predominant cause of late graft loss is antibody-mediated rejection (AMR), a process whereby injury to the organ is caused by donor-specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Pineda, Silvia, Sigdel, Tara K., Chen, Jieming, Jackson, Annette M., Sirota, Marina, Sarwal, Minnie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723302/
https://www.ncbi.nlm.nih.gov/pubmed/29259604
http://dx.doi.org/10.3389/fimmu.2017.01687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723302/
https://www.ncbi.nlm.nih.gov/pubmed/29259604
http://dx.doi.org/10.3389/fimmu.2017.01687

Ejemplares similares